Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in BCDA held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | CM Management, LLC | 130K | $157K | 0.0% | 2.242% | 0.13% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 125K | $151K | β | 2.149% | 0.00% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 94K | $114K | +42.9% | 1.626% | 0.00% |
| 4 | VANGUARD FIDUCIARY TRUST CO | 66K | $80K | β | 1.143% | 0.00% |
| 5 | CITADEL ADVISORS LLC | 63K | $77K | -32.8% | 1.093% | 0.00% |
| 6 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 39K | $47K | +0.1% | 0.670% | 0.00% |
| 7 | Pingora Partners LLC | 36K | $43K | +1077.2% | 0.616% | 0.03% |
| 8 | BROWN ADVISORY INC | 36K | $43K | 0.0% | 0.613% | 0.00% |
| 9 | XTX Topco Ltd | 24K | $29K | +49.0% | 0.419% | 0.00% |
| 10 | COMMONWEALTH EQUITY SERVICES, LLC | 18K | $22K | 0.0% | 0.315% | 0.00% |
| 11 | TWO SIGMA SECURITIES, LLC | 15K | $18K | β | 0.255% | 0.00% |
| 12 | RENAISSANCE TECHNOLOGIES LLC | 14K | $17K | β | 0.240% | 0.00% |
| 13 | MORGAN STANLEY | 3K | $4K | 0.0% | 0.053% | 0.00% |
| 14 | Tower Research Capital LLC (TRC) | 3K | $4K | -9.6% | 0.051% | 0.00% |
| 15 | Vanguard Global Advisers, LLC | 268 | $324 | β | 0.005% | 0.00% |
| 16 | Virtu Financial LLC | 20K | $25 | β | 0.351% | 0.00% |
| 17 | SBI Securities Co., Ltd. | 9 | $11 | +50.0% | 0.000% | 0.00% |
| 18 | ADVISOR GROUP HOLDINGS, INC. | 1 | $1 | 0.0% | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in BCDA β a direct measure of their conviction.
Filings activity in BCDA during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 18 | 5.3% | 15.80% | +1.57 pp | $1M | +11% |
| Q4 2025 | 19 | +5.6% | 14.23% | +3.88 pp | $1M | +38% |
| Q3 2025 | 18 | +5.9% | 10.35% | 0.59 pp | $1M | 5.4% |
| Q2 2025 | 17 | +31% | 10.94% | 0.50 pp | $1M | 4.4% |
| Q1 2025 | 13 | 7.1% | 11.44% | +6.11 pp | $1M | +114% |
| Q4 2024 | 14 | +40% | 5.33% | 0.87 pp | $0M | 14% |
| Q3 2024 | 10 | +0.0% | 6.20% | +1.81 pp | $0M | +41% |
| Q2 2024 | 10 | β | 4.39% | β | $0M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying BCDA stock.
Based on Q1 2026 13F filings, institutional ownership of BioCardia, Inc. stands at 15.8%, held across 18 reporting institutions.
CM Management, LLC is the largest reported institutional holder of BCDA, with approximately 130,000 shares worth $0.00B as of Q1 2026.
Yes β 4 widely-followed marquee investors appear among the top 25 institutional holders of BCDA, including CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA SECURITIES, LLC, RENAISSANCE TECHNOLOGIES LLC.
Our composite Smart Money Score for BCDA is 66 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
6 institutions opened new positions in BCDA during Q1 2026, while 7 fully exited. 4 added to existing positions and 7 trimmed.
BCDA institutional ownership rose by 1.57 percentage points quarter-over-quarter, with a net change of -1 holders.
The top 10 institutions account for 94.7% of all reported 13F value in BCDA, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.